✦ LIBER ✦

16LBA VEGFR-1 polymorphisms as potential predictors of clinical outcome in bevacizumab-treated patients with metastatic pancreatic cancer

✍ Scribed by D. Lambrechts; P. Delmar; I. Buysschaert; B. Claes; B.T. Yesilyurt; C. Verslype; D. Foernzler; P. Carmeliet; S. Scherer; E. Van Cutsem

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP1A1*2A polymorphism as a predictor of

✍ Qiang Nie; Xue-ning Yang; She-juan An; Xu-chao Zhang; Jin-ji Yang; Wen-zhao Zhon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 289 KB

710: Clinical implication of UGT1A1 prom

✍ Wang, J.; Lu, C.Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The genotyping of UGT1A1 polymorphism fo

✍ Lu, Chien-Yu; Tsai, Hsiang-Lin; Wang, Jaw-Yuan 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 169 KB

The epidermal growth factor receptor int

✍ Qiang Nie; Zhen Wang; Guo-chun Zhang; She-juan An; Jia-yin Lin; Ai-lin Guo; Rong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 255 KB

OP62 Polymorphisms in AKT1 and EGFR as p

✍ E. Giovannetti; P. Zucali; C. Tibaldi; E. Smit; A. Falcone; A. Santoro; L. Leon; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Retrospective analysis of clinical resul

✍ Kan Yonemori; Yasuhiro Shimada; Ayumu Goto; Takashi Ura; Tatsuhiro Arai; Tetsuya 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 171 KB